Advanced BioMedical Technologies Accounts Payable

Advanced BioMedical Technologies posts a accounts payable of $890K as of July 2022. That compares with $1.2M in the prior-year period — down 23.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Advanced BioMedical Technologies's accounts payable was $1.2M. The latest reading is $890K — a 23.6% year-over-year decrease (period ending July 2022). Use the history and growth charts on this page for a longer lookback.

Accounts Payable is one piece of Advanced BioMedical Technologies's financial statement story. At $890K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ABMT's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Advanced BioMedical Technologies's other metric pages and overview cover the third.